Cefamandole nafate

头孢孟多酯钠

Report date: 2022/05/16 10:20:29
NME

Base Information

Drug NameCefamandole nafate
Drug Alias NameCefamandolum头孢孟多钠Cefamandole Sodium甲酰苄四唑头孢菌素钠cefamandol +[14] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics > Cephalosporins antibiotics
Mechanisms of ActionBacterial penicillin-binding protein inhibitorsCell wall inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsBacterial Infections
Approved Indications in ChinaBacterial Infections
Original Approved Country/TerritoryUnited States
Original Approved Date1978/09/27
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Sph New Asia Pharmaceutical Co Ltd
Inactive CompaniesEli Lilly And Company
Active IndicationsBacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeJ01DC03
Related LinksWikipediaDrugBankKEGG